Study on infusion rate of snake antivenom therapy
Not Applicable
Completed
- Conditions
- Snakebites requiring antivenom administration
- Registration Number
- SLCTR/2007/005
- Lead Sponsor
- IRQUE Project
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Not specified
- Target Recruitment
- 206
Inclusion Criteria
Patients with a possible clinical diagnosis of a snakebite
Exclusion Criteria
* Under 14 years of age * Pregnant ladies * Previous administration of antivenom * Refusal of consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie antivenom efficacy in snakebite treatment?
How does the infusion rate of antivenom compare to standard-of-care protocols in clinical outcomes?
What biomarkers are used to predict response to antivenom therapy in envenomation syndromes?
What adverse events are associated with rapid antivenom infusion and how are they managed?
Are there combination therapies or alternative antivenoms that enhance treatment for viper or elapid snakebites?